Citi analyst Tyler Radke raised the firm’s price target on DocuSign to $87 from $86 and keeps a Buy rating on the shares following the Q2 report. A small billings beat but a larger revenue and profitability beat offered more signs of validation that Docusign continues to stabilize growth and find incremental efficiency, the analyst tells investors in a research note. The firm remains encouraged by DocuSign’s “various growth signals.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
